PAMS
CLDX icon

Pictet Asset Management (Switzerland)’s Celldex Therapeutics CLDX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		$60.9M Buy
1,794,048
+1,014,420
+130% +$34.4M 0.07% 262
2023
Q1 		$28.1M Buy
+779,628
New +$28.1M 0.04% 384